Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Acceleron sees Q2 REBLOZYL royalty revenue $25.6M vs. $22.4 last quarter » 07:30
07/28/21
07/28
07:30
07/28/21
07:30
XLRN

Acceleron

$116.91 /

-3.32 (-2.76%)

, BMY

Bristol-Myers

$67.44 /

-0.25 (-0.37%)

Acceleron Pharma (XLRN)…

Acceleron Pharma (XLRN) announced net sales of REBLOZYL, luspatercept-aamt, as reported by its global collaborator, Bristol Myers Squibb (BMY), were approximately $128M for the second quarter ended June 30,. Acceleron expects to report royalty revenue of approximately $25.6M from net sales of REBLOZYL in the second quarter ended June 30, 2021. This compares with approximately $22.4 million royalty revenue of a from approximately $112 million of net sales of REBLOZYL for the first quarter ended March 31, 2021. The preliminary unaudited revenue estimate for the quarter ended June 30, 2021 included in this release is the responsibility of management and is subject to the completion of the Company's customary quarter-end financial closing procedures, including management's review and finalization, as well as review procedures by the Company's independent registered public accounting firm, which have not yet been completed. During the course of the Company's review process, items may be identified that would require it to make adjustments, which could result in material changes to the Company's preliminary unaudited estimated financial results. Consequently, this revenue estimate should not be viewed as a substitute for the Company's earnings release and Quarterly Report on Form 10-Q.

ShowHide Related Items >><<
XLRN Acceleron
$116.91 /

-3.32 (-2.76%)

BMY Bristol-Myers
$67.44 /

-0.25 (-0.37%)

XLRN Acceleron
$116.91 /

-3.32 (-2.76%)

07/19/21 Wolfe Research
Acceleron assumed with an Outperform at Wolfe Research
06/24/21 Oppenheimer
Acceleron price target raised to $160 from $141 at Oppenheimer
06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
BMY Bristol-Myers
$67.44 /

-0.25 (-0.37%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
XLRN Acceleron
$116.91 /

-3.32 (-2.76%)

BMY Bristol-Myers
$67.44 /

-0.25 (-0.37%)

BMY Bristol-Myers
$67.44 /

-0.25 (-0.37%)

BMY Bristol-Myers
$67.44 /

-0.25 (-0.37%)

BMY Bristol-Myers
$67.44 /

-0.25 (-0.37%)

Over a week ago
Initiation
Acceleron assumed with an Outperform at Wolfe Research » 06:52
07/19/21
07/19
06:52
07/19/21
06:52
XLRN

Acceleron

$117.12 /

+2.56 (+2.23%)

Wolfe Research analyst…

Wolfe Research analyst Andrew Galler assumed coverage of Acceleron with an Outperform rating and $183 price target, citing his view on sotatercept's STELLAR trial, the outlook for Reblozyl, and the company's early-stage pipeline.

ShowHide Related Items >><<
XLRN Acceleron
$117.12 /

+2.56 (+2.23%)

XLRN Acceleron
$117.12 /

+2.56 (+2.23%)

06/24/21 Oppenheimer
Acceleron price target raised to $160 from $141 at Oppenheimer
06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
XLRN Acceleron
$117.12 /

+2.56 (+2.23%)

Over a month ago
Recommendations
Acceleron price target raised to $160 from $141 at Oppenheimer » 08:07
06/24/21
06/24
08:07
06/24/21
08:07
XLRN

Acceleron

$122.23 /

-2.28 (-1.83%)

Oppenheimer analyst…

Oppenheimer analyst Leland Gershell raised the firm's price target on Acceleron to $160 from $141 and keeps an Outperform rating on the shares. At Tuesday's event, Acceleron management, along with several thought-leading advisors, detailed the design of the three Phase 3 trials that compose sotatercept's broad registration program in PAH as well as revealed Phase 2 plans in pulmonary hypertension due to left heart disease, the analyst tells investors in a research note.

ShowHide Related Items >><<
XLRN Acceleron
$122.23 /

-2.28 (-1.83%)

XLRN Acceleron
$122.23 /

-2.28 (-1.83%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
XLRN Acceleron
$122.23 /

-2.28 (-1.83%)

  • 01
    Jul
Conference/Events
Acceleron to host virtual research and development day » 07:55
06/22/21
06/22
07:55
06/22/21
07:55
XLRN

Acceleron

$128.36 /

+0.06 (+0.05%)

Virtual Research and…

Virtual Research and Development day to be held on June 22 at 8 am. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$128.36 /

+0.06 (+0.05%)

XLRN Acceleron
$128.36 /

+0.06 (+0.05%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
XLRN Acceleron
$128.36 /

+0.06 (+0.05%)

  • 01
    Jul
Conference/Events
Acceleron to host virtual research and development day » 04:55
06/22/21
06/22
04:55
06/22/21
04:55
XLRN

Acceleron

$128.36 /

+0.06 (+0.05%)

Virtual Research and…

Virtual Research and Development day to be held on June 22 at 8 am. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$128.36 /

+0.06 (+0.05%)

XLRN Acceleron
$128.36 /

+0.06 (+0.05%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
XLRN Acceleron
$128.36 /

+0.06 (+0.05%)

  • 01
    Jul
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/17/21
06/17
04:55
06/17/21
04:55
APTO

Aptose Biosciences

$3.39 /

-0.115 (-3.29%)

, MBIO

Mustang Bio

$3.48 /

-0.09 (-2.52%)

, QURE

uniQure

$34.41 /

-0.015 (-0.04%)

, RIGL

Rigel Pharmaceuticals

$4.20 /

-0.07 (-1.64%)

, MGTA

Magenta Therapeutics

$11.13 /

-0.2 (-1.77%)

, MEIP

MEI Pharma

$3.32 /

+0.22 (+7.10%)

, CRIS

Curis

$7.58 /

-0.07 (-0.92%)

, XLRN

Acceleron

$126.85 /

-1.78 (-1.38%)

, EPZM

Epizyme

$8.81 /

+0.025 (+0.28%)

, INCY

Incyte

$83.13 /

+0.44 (+0.53%)

, ORTX

Orchard Therapeutics

$4.79 /

-0.06 (-1.24%)

, TGTX

TG Therapeutics

$36.64 /

-0.8 (-2.14%)

, EQ

Equillium

$5.87 /

-0.17 (-2.81%)

, JAZZ

Jazz Pharmaceuticals

$181.08 /

-2.19 (-1.19%)

, VRTX

Vertex Pharmaceuticals

$187.51 /

-1.43 (-0.76%)

, SGEN

Seagen

$151.42 /

-1.93 (-1.26%)

, IMRA

Imara

$7.76 /

-0.5 (-6.05%)

, GBT

Global Blood Therapeutics

$38.21 /

-1.39 (-3.51%)

, BGNE

BeiGene

$333.73 /

+2.27 (+0.68%)

, APLS

Apellis

$59.71 /

-0.97 (-1.60%)

, AGIO

Agios Pharmaceuticals

$58.82 /

+0.63 (+1.08%)

, FMTX

Forma Therapeutics

$24.23 /

+0.1 (+0.41%)

, KROS

Keros Therapeutics

$52.91 /

+0.32 (+0.61%)

, CYAD

Celyad

$5.33 /

-0.11 (-2.02%)

, ALXN

Alexion

$180.56 /

-1.34 (-0.74%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

SGEN Seagen
$151.42 /

-1.93 (-1.26%)

RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

QURE uniQure
$34.41 /

-0.015 (-0.04%)

ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

MGTA Magenta Therapeutics
$11.13 /

-0.2 (-1.77%)

MEIP MEI Pharma
$3.32 /

+0.22 (+7.10%)

MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

KROS Keros Therapeutics
$52.91 /

+0.32 (+0.61%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

IMRA Imara
$7.76 /

-0.5 (-6.05%)

GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

CYAD Celyad
$5.33 /

-0.11 (-2.02%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

BGNE BeiGene
$333.73 /

+2.27 (+0.68%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

AGIO Agios Pharmaceuticals
$58.82 /

+0.63 (+1.08%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.41 /

-0.015 (-0.04%)

06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.13 /

-0.2 (-1.77%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.32 /

+0.22 (+7.10%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$7.58 /

-0.07 (-0.92%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$83.13 /

+0.44 (+0.53%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$5.87 /

-0.17 (-2.81%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$151.42 /

-1.93 (-1.26%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$7.76 /

-0.5 (-6.05%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$333.73 /

+2.27 (+0.68%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$59.71 /

-0.97 (-1.60%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.82 /

+0.63 (+1.08%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.91 /

+0.32 (+0.61%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.33 /

-0.11 (-2.02%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$180.56 /

-1.34 (-0.74%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

SGEN Seagen
$151.42 /

-1.93 (-1.26%)

RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

QURE uniQure
$34.41 /

-0.015 (-0.04%)

ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

MGTA Magenta Therapeutics
$11.13 /

-0.2 (-1.77%)

MEIP MEI Pharma
$3.32 /

+0.22 (+7.10%)

MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

KROS Keros Therapeutics
$52.91 /

+0.32 (+0.61%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

IMRA Imara
$7.76 /

-0.5 (-6.05%)

GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

BGNE BeiGene
$333.73 /

+2.27 (+0.68%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

AGIO Agios Pharmaceuticals
$58.82 /

+0.63 (+1.08%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

RIGL Rigel Pharmaceuticals
$4.20 /

-0.07 (-1.64%)

ORTX Orchard Therapeutics
$4.79 /

-0.06 (-1.24%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

EPZM Epizyme
$8.81 /

+0.025 (+0.28%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

TGTX TG Therapeutics
$36.64 /

-0.8 (-2.14%)

SGEN Seagen
$151.42 /

-1.93 (-1.26%)

QURE uniQure
$34.41 /

-0.015 (-0.04%)

MBIO Mustang Bio
$3.48 /

-0.09 (-2.52%)

JAZZ Jazz Pharmaceuticals
$181.08 /

-2.19 (-1.19%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

IMRA Imara
$7.76 /

-0.5 (-6.05%)

GBT Global Blood Therapeutics
$38.21 /

-1.39 (-3.51%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

APTO Aptose Biosciences
$3.39 /

-0.115 (-3.29%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

VRTX Vertex Pharmaceuticals
$187.51 /

-1.43 (-0.76%)

INCY Incyte
$83.13 /

+0.44 (+0.53%)

FMTX Forma Therapeutics
$24.23 /

+0.1 (+0.41%)

EQ Equillium
$5.87 /

-0.17 (-2.81%)

CRIS Curis
$7.58 /

-0.07 (-0.92%)

APLS Apellis
$59.71 /

-0.97 (-1.60%)

ALXN Alexion
$180.56 /

-1.34 (-0.74%)

Conference/Events
Acceleron to host virtual research and development day » 14:24
06/16/21
06/16
14:24
06/16/21
14:24
XLRN

Acceleron

$126.85 /

-1.78 (-1.38%)

Virtual Research and…

Virtual Research and Development day to be held on June 22 at 8 am. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
XLRN Acceleron
$126.85 /

-1.78 (-1.38%)

  • 01
    Jul
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/16/21
06/16
04:55
06/16/21
04:55
APTO

Aptose Biosciences

$3.50 /

-0.21 (-5.66%)

, MBIO

Mustang Bio

$3.57 /

-0.115 (-3.13%)

, QURE

uniQure

$34.46 /

-0.43 (-1.23%)

, RIGL

Rigel Pharmaceuticals

$4.27 /

-0.1 (-2.29%)

, MGTA

Magenta Therapeutics

$11.38 /

+0.05 (+0.44%)

, MEIP

MEI Pharma

$3.10 /

-0.15 (-4.62%)

, CRIS

Curis

$7.61 /

-0.44 (-5.47%)

, XLRN

Acceleron

$128.63 /

-2.39 (-1.82%)

, EPZM

Epizyme

$8.79 /

-0.025 (-0.28%)

, INCY

Incyte

$82.69 /

+0.11 (+0.13%)

, ORTX

Orchard Therapeutics

$4.85 /

-0.19 (-3.77%)

, TGTX

TG Therapeutics

$37.42 /

-0.88 (-2.30%)

, EQ

Equillium

$6.05 /

+0.05 (+0.83%)

, JAZZ

Jazz Pharmaceuticals

$183.42 /

-2.7 (-1.45%)

, VRTX

Vertex Pharmaceuticals

$188.94 /

-5.87 (-3.01%)

, SGEN

Seagen

$153.20 /

-2.99 (-1.91%)

, IMRA

Imara

$8.26 /

-0.44 (-5.06%)

, GBT

Global Blood Therapeutics

$39.60 /

-0.65 (-1.61%)

, BGNE

BeiGene

$332.97 /

-9.75 (-2.84%)

, APLS

Apellis

$60.63 /

-4.27 (-6.58%)

, AGIO

Agios Pharmaceuticals

$58.23 /

+0.04 (+0.07%)

, FMTX

Forma Therapeutics

$24.13 /

-0.09 (-0.37%)

, KROS

Keros Therapeutics

$52.55 /

-0.455 (-0.86%)

, CYAD

Celyad

$5.44 /

+0.03 (+0.55%)

, ALXN

Alexion

$181.90 /

+0.25 (+0.14%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

CYAD Celyad
$5.44 /

+0.03 (+0.55%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.46 /

-0.43 (-1.23%)

06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$7.61 /

-0.44 (-5.47%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.69 /

+0.11 (+0.13%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.05 /

+0.05 (+0.83%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$153.20 /

-2.99 (-1.91%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.26 /

-0.44 (-5.06%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$60.63 /

-4.27 (-6.58%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.44 /

+0.03 (+0.55%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.90 /

+0.25 (+0.14%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
APTO

Aptose Biosciences

$3.71 /

-0.04 (-1.07%)

, MBIO

Mustang Bio

$3.68 /

-0.11 (-2.90%)

, QURE

uniQure

$34.89 /

-1.24 (-3.43%)

, RIGL

Rigel Pharmaceuticals

$4.37 /

+0.35 (+8.71%)

, MGTA

Magenta Therapeutics

$11.33 /

-0.22 (-1.90%)

, MEIP

MEI Pharma

$3.28 /

+0.005 (+0.15%)

, CRIS

Curis

$8.05 /

+0.05 (+0.63%)

, XLRN

Acceleron

$131.02 /

-2.4 (-1.80%)

, EPZM

Epizyme

$8.81 /

+0.305 (+3.59%)

, INCY

Incyte

$82.61 /

+0.03 (+0.04%)

, ORTX

Orchard Therapeutics

$5.04 /

-0.09 (-1.75%)

, TGTX

TG Therapeutics

$38.30 /

+0.49 (+1.30%)

, EQ

Equillium

$6.00 /

-0.12 (-1.96%)

, JAZZ

Jazz Pharmaceuticals

$186.45 /

+0.15 (+0.08%)

, VRTX

Vertex Pharmaceuticals

$194.81 /

+1.78 (+0.92%)

, SGEN

Seagen

$156.25 /

-0.21 (-0.13%)

, IMRA

Imara

$8.70 /

+0.135 (+1.58%)

, GBT

Global Blood Therapeutics

$40.25 /

-0.32 (-0.79%)

, BGNE

BeiGene

$344.52 /

-5.39 (-1.54%)

, APLS

Apellis

$64.90 /

+2.8 (+4.51%)

, AGIO

Agios Pharmaceuticals

$58.20 /

+0.43 (+0.74%)

, FMTX

Forma Therapeutics

$24.22 /

+1.41 (+6.18%)

, KROS

Keros Therapeutics

$53.00 /

+1.64 (+3.19%)

, CYAD

Celyad

$5.41 /

-0.29 (-5.09%)

, ALXN

Alexion

$181.65 /

+0.08 (+0.04%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

CYAD Celyad
$5.41 /

-0.29 (-5.09%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.89 /

-1.24 (-3.43%)

06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.05 /

+0.05 (+0.63%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.61 /

+0.03 (+0.04%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.00 /

-0.12 (-1.96%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$156.25 /

-0.21 (-0.13%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.70 /

+0.135 (+1.58%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$64.90 /

+2.8 (+4.51%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.41 /

-0.29 (-5.09%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.65 /

+0.08 (+0.04%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/14/21
06/14
04:55
06/14/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.